Literature DB >> 6308989

CT prognostic criteria of survival after malignant glioma surgery.

J Andreou, A E George, A Wise, M de Leon, I I Kricheff, J Ransohoff, S H Foo.   

Abstract

The serial pre- and postoperative computed tomographic (CT) scans of 115 patients entered in the Cooperative Brain Tumor Study between 1975 and 1982 were analyzed in order to define CT prognostic criteria and to test the hypothesis that radical glioma surgery prolongs patient survival. The CT parameters of mass size, associated edema, and intensity of enhancement were quantitated on all scans. Clinical parameters evaluated included gender, age, length of survival, and useful (Karnofsky greater than 30) survival. Data analyses indicated postoperative residual tumor burden was inversely related to length of survival (p less than 0.01). Postoperative associated edema and intensity of image enhancement were also of prognostic value and showed an inverse relation to survival. Younger patients proved more likely than older patients to attain long-term survival. Residual tumor burden of less than 45 mm diameter on postoperative CT scans was associated with 70% chance of long-term survival. These findings support the radical surgical management of glioma.

Entities:  

Mesh:

Year:  1983        PMID: 6308989      PMCID: PMC8334985     

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  16 in total

Review 1.  The role of image-guided technology in the surgical planning and resection of gliomas.

Authors:  G H Barnett
Journal:  J Neurooncol       Date:  1999-05       Impact factor: 4.130

Review 2.  Historical development of surgery for glial tumors.

Authors:  M Salcman
Journal:  J Neurooncol       Date:  1999-05       Impact factor: 4.130

3.  Interstitial chemotherapy plus systemic chemotherapy for glioblastoma patients: improved survival in sequential studies.

Authors:  A Boiardi; A Silvani; A Pozzi; L Fariselli; G Broggi; A Salmaggi
Journal:  J Neurooncol       Date:  1999-01       Impact factor: 4.130

4.  Surgical management of newly diagnosed glioblastoma in adults: role of cytoreductive surgery.

Authors:  Timothy C Ryken; Bruce Frankel; Terrance Julien; Jeffrey J Olson
Journal:  J Neurooncol       Date:  2008-08-20       Impact factor: 4.130

5.  The influence of the extent of surgery on the neurological function and survival in malignant glioma. A retrospective analysis in 243 patients.

Authors:  C J Vecht; C J Avezaat; W L van Putten; W M Eijkenboom; S Z Stefanko
Journal:  J Neurol Neurosurg Psychiatry       Date:  1990-06       Impact factor: 10.154

6.  Does extent of surgery influence outcome for astrocytoma with atypical or anaplastic foci (AAF)? A report from three Radiation Therapy Oncology Group (RTOG) trials.

Authors:  W J Curran; C B Scott; J Horton; J S Nelson; A S Weinstein; D F Nelson; A J Fischbach; C H Chang; M Rotman; S O Asbell
Journal:  J Neurooncol       Date:  1992-03       Impact factor: 4.130

7.  Brain Tumor Working Group Report on the 9th International Conference on Brain Tumor Research and Therapy. Organ System Program, National Cancer Institute.

Authors:  D F Deen; A Chiarodo; E A Grimm; J R Fike; M A Israel; L E Kun; V A Levin; L J Marton; R J Packer; A E Pegg
Journal:  J Neurooncol       Date:  1993-06       Impact factor: 4.130

Review 8.  Evidence and context of use for contrast enhancement as a surrogate of disease burden and treatment response in malignant glioma.

Authors:  Benjamin M Ellingson; Patrick Y Wen; Timothy F Cloughesy
Journal:  Neuro Oncol       Date:  2018-03-27       Impact factor: 12.300

9.  Imaging features of invasion and preoperative and postoperative tumor burden in previously untreated glioblastoma: Correlation with survival.

Authors:  Rohan Ramakrishna; Jason Barber; Greg Kennedy; Adnan Rizvi; Robert Goodkin; Richard H Winn; George A Ojemann; Mitchel S Berger; Alexander M Spence; Robert C Rostomily
Journal:  Surg Neurol Int       Date:  2010-08-10

10.  Multivariate analysis of clinical prognostic factors in patients with glioblastoma multiforme treated with a combined modality approach.

Authors:  Branislav Jeremic; Biljana Milicic; Danica Grujicic; Aleksandar Dagovic; Jasna Aleksandrovic
Journal:  J Cancer Res Clin Oncol       Date:  2003-07-15       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.